Rila Therapeutics

San Francisco, United States

Rila Therapeutics helps with anti-fibrotic treatments, focusing on a groundbreaking HIPK2 inhibitor for kidney fibrosis.

$7.0M raised

Jan 2025

Venture - Series Unknown

Health Care Personal Health Therapeutics

Top Investors

ShangPharma Innovation

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Rila Therapeutics

How much funding has Rila Therapeutics raised?

Rila Therapeutics has raised $7.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2025.

Who are Rila Therapeutics's investors?

Rila Therapeutics's investors include ShangPharma Innovation.

Where is Rila Therapeutics headquartered?

Rila Therapeutics is headquartered in San Francisco, United States.

What does Rila Therapeutics do?

Rila Therapeutics helps with anti-fibrotic treatments, focusing on a groundbreaking HIPK2 inhibitor for kidney fibrosis.

What stage is Rila Therapeutics at?

Rila Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 6, 2025.

MLA

"Rila Therapeutics — Funding & Investors." VCBacked, January 6, 2025, https://www.vcbacked.co/company/rila-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2025). Rila Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/rila-therapeutics

Wikipedia (cite web)

{{cite web |title=Rila Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/rila-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 6, 2025.